Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Assets (2016 - 2025)

Amicus Therapeutics' Return on Assets history spans 15 years, with the latest figure at 0.03% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 4.0% year-over-year to 0.03%, compared with a TTM value of 0.03% through Dec 2025, up 4.0%, and an annual FY2025 reading of 0.03%, up 4.0% over the prior year.
  • Return on Assets for Q4 2025 was 0.03% at Amicus Therapeutics, down from 0.02% in the prior quarter.
  • The five-year high for Return on Assets was 0.02% in Q3 2025, with the low at 0.35% in Q2 2022.
  • Average Return on Assets over 5 years is 0.21%, with a median of 0.25% recorded in 2023.
  • Year-over-year, Return on Assets dropped -6bps in 2022 and then rose 16bps in 2025.
  • Tracing FOLD's Return on Assets over 5 years: stood at 0.27% in 2021, then fell by -19bps to 0.32% in 2022, then surged by 38bps to 0.2% in 2023, then skyrocketed by 64bps to 0.07% in 2024, then soared by 58bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Return on Assets are 0.03% (Q4 2025), 0.02% (Q3 2025), and 0.05% (Q2 2025).